MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Novel Recessive Mitochondrial Mutations Causing Leigh’s Syndrome and Movement Disorders

    B. Barton, C. Toro (Chicago, IL, USA)

  • Novel walker attachment for gait dysfunction in Parkinson’s disease: Case report

    C. Gill, P. Schmitt, J. Karl, L. Verhagen Metman (Chicago, IL, USA)

  • Nucleus basalis of Meynert free-water distinguishes and predicts cognitive impairment and longitudinally correlates with cognitive changes in early Parkinson’s disease

    T. Guttuso, Jr., D. Tosun, R. Zivadinov, O. Pasternak, D. Weintraub, N. Bergsland (Buffalo, NY, USA)

  • Nurse led intrajejunal levodopa pathway for a regional neurosciences centre

    P. Duggan-Carter, J. Cosgrove, J. Alty (Leeds, United Kingdom)

  • NUS1 polymorphisms modify the risk and age at onset of Parkinson’s disease

    L. Jiang, J. Mei, Y. Zhao, R. Zhang, H. Pan, Y. Yang, Q. Sun, Q. Xu, X. Yan, J. Tan, J. Li, B. Tang, J. Guo (Changsha, China)

  • Nutrient patterns in Parkinson’s disease: A case-control study

    S. Diaconu, A. Maceasa, B. Ciopleias, R. Zosin, C. Falup-Pecurariu (Braşov, Romania)

  • O-arm stereotactic imaging in deep brain stimulation surgery workflow: A utility and cost-effectiveness analysis

    L. Furlanetti, H. Hasegawa, A. Oviedova, A. Raslan, M. Samuel, R. Selway, K. Ashkan (London, United Kingdom)

  • Object and action naming test in cognitive subtypes in nondemented patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

  • Objective measurement of limb bradykinesia using marker-less tracking algorithm with 2D-video of PD patients

    J.H Shin, S.H Jeon, R. Kim, S.M Park, J.H Choi, J.N Ong, H.J Kim, B. Jeon (Seoul, Republic of Korea)

  • Objective Measurement of Muscle Mechanical Properties using a Myometric Device in People with Parkinson’s Disease in a Clinical Setting in Africa

    M. Agoriwo, P. Muckelt, C. Osei-Yeboah, B. Sankah, S. Agyapong-Badu, A. Akpalu, M. Stokes (Accra, Ghana)

  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley